Coming Upswing in Cancer Raises Concerns, But Industry May Be Ready
The World Health Organization reports that cancer cases are expected to rise significantly by 2050, highlighting global inequities in care and the need for early detection. New industry initiatives, such as PreOncology, are emerging to assist primary care physicians in managing the growing burden of the disease.
Why it matters
As cancer rates climb, the shift toward early, comprehensive screening and primary care integration is critical for improving long-term survival rates.
Cancer will touch 92% of people, either directly or through a close family member, the World Health Organization’s latest annual report on cancer warns. One in five people will develop the disease themselves. The report also found widespread global inequities in access to prevention, diagnosis, treatment and care.
This global view of cancer occurrence, diagnosis, and treatment, comes at a time when some in industry feel oncology is undergoing some dramatic technological transformations. Companies positioned to help spark change in how we meet the growing challenge of cancer around the world include those that provide direct to consumer genomic (e.g. Grail) or MRI (e.g. Prenuvo) testing for the disease. But whole new disciplines are likely to emerge, such as PreOncology, a new service that offers very early, comprehensive, cancer screening through primary care physicians (PCPs). PreOncology launched in Florida July 1.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in